http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113402529-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
| filingDate | 2021-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113402529-B |
| titleOfInvention | Trimeric guaiane type sesquiterpenoids, preparation method and application thereof |
| abstract | The invention discloses a trimeric guaiane type sesquiterpenoids with anti-tumor activity and a preparation method and application thereof. The trimeric sesquiterpene compound is Ainsfragolide A extracted and separated from Ainsfragolide, and a chemical structural formula of the trimeric sesquiterpene compound is given as follows: the molecule is C 45 H 46 O 10 . In vitro anti-tumor activity research shows that the guaiane type trimeric sesquiterpene compound provided by the invention has strong anti-tumor activity on various tumor cells, including liver cancer, glioma cancer, pancreatic cancer, cervical cancer and the like, and is expected to be developed into a new anti-tumor medicament. |
| priorityDate | 2021-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.